Subcutaneous Drug Development & Delivery Consortium

About

The Subcutaneous Drug Development & Delivery Consortium (SC Consortium) aims to collaboratively transform patient care and improve patient outcomes by leading fundamental advancements in the SC drug development and delivery space, in a precompetitive manner. The SC Consortium is led by leaders in the SC industry, who focus on driving forward activities and efforts that allow participating organizations to provide value to the entire SC ecosystem. You can visit the website to learn more about our ongoing efforts, from workshops to data-pooling to manuscript development, and more!"

Our 2022 sub-team roadmaps are focused on 5 key areas fundamental to development of drug-device combination products:

• High Dose / Large Volume SC Technology
• Patient Preference and Experience
• Bioavailability
• Immunogenicity
• Clinical Trial Strategy

Keywords

pharmaceutical, sc bioavailability, high dose, large volume, patient preferences, patient experiece, immunogenicity, clinical trials, sc product development, combination products, payer preferences, drug development, drug delivery, biologics, device, ddc, sustainability

Amenities

No amenities listed yet

Upcoming Events

No upcoming events scheduled

Frequently Asked Questions

No reviews yet. Be the first to review!

Social Links

No social media links available

Photo Gallery

No photos available

Contact Information

Business Info

Location

Business Hours

Business hours not available